Literature DB >> 9445415

Demyelinating diseases--new pathological insights, new therapeutic targets.

S G Waxman.   

Abstract

Entities:  

Mesh:

Year:  1998        PMID: 9445415     DOI: 10.1056/NEJM199801293380610

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  42 in total

Review 1.  The neuron as a dynamic electrogenic machine: modulation of sodium-channel expression as a basis for functional plasticity in neurons.

Authors:  S G Waxman
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2000-02-29       Impact factor: 6.237

2.  Diffusion-weighted MR imaging of multiple sclerosis: added clinical value or "just another pretty face?".

Authors:  M H Lev
Journal:  AJNR Am J Neuroradiol       Date:  2000-05       Impact factor: 3.825

3.  Analysis of normal-appearing white matter in multiple sclerosis: comparison of diffusion tensor MR imaging and magnetization transfer imaging.

Authors:  A C Guo; V L Jewells; J M Provenzale
Journal:  AJNR Am J Neuroradiol       Date:  2001 Nov-Dec       Impact factor: 3.825

4.  Abnormal Purkinje cell activity in vivo in experimental allergic encephalomyelitis.

Authors:  Carl Y Saab; Matthew J Craner; Yuko Kataoka; Stephen G Waxman
Journal:  Exp Brain Res       Date:  2004-04-29       Impact factor: 1.972

Review 5.  Recombinant T cell receptor ligands: immunomodulatory, neuroprotective and neuroregenerative effects suggest application as therapy for multiple sclerosis.

Authors:  Halina Offner; Sushmita Sinha; Chunhe Wang; Gregory G Burrows; Arthur A Vandenbark
Journal:  Rev Neurosci       Date:  2008       Impact factor: 4.353

6.  Axonal degeneration and progressive neurologic disability in multiple sclerosis.

Authors:  Carl Bjartmar; Bruce D Trapp
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

7.  Expression of beta2 adrenoreceptors on peripheral blood mononuclear cells in patients with primary and secondary progressive multiple sclerosis: a longitudinal six month study.

Authors:  Y Zoukos; T N Thomaides; D Kidd; M L Cuzner; A Thompson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-02       Impact factor: 10.154

8.  Spatiotemporal patterns of dexamethasone-induced Ras protein 1 expression in the central nervous system of rats with experimental autoimmune encephalomyelitis.

Authors:  Heng Gao; Ying Gao; Xiaohong Li; Aiguo Shen; Meijuan Yan
Journal:  J Mol Neurosci       Date:  2010-01-19       Impact factor: 3.444

9.  Vocal symptoms and acoustic changes in relation to the expanded disability status scale, duration and stage of disease in patients with multiple sclerosis.

Authors:  Bassem Yamout; Nabil Fuleihan; Taghrid Hajj; Abla Sibai; Omar Sabra; Hani Rifai; Abdul-Latif Hamdan
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-06-10       Impact factor: 2.503

10.  Neurological functional recovery after thymosin beta4 treatment in mice with experimental auto encephalomyelitis.

Authors:  J Zhang; Z G Zhang; D Morris; Y Li; C Roberts; S B Elias; M Chopp
Journal:  Neuroscience       Date:  2009-09-25       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.